Here’s your Investing Action Plan for Tuesday: what you need to know as an investor for the coming day.
Fan favorites like Apple (AAPL) and Facebook (FB) give current stockholders reason to cheer but are well above buying range. Even Apple bull Warren Buffett wouldn’t buy its shares again now and is skittish about Amazon.com (AMZN), despite admitting that he missed out earlier. But there are some hot, albeit lesser-known, stocks that are still in buy zones, such as Microchip Technology (MCHP) and Electronic Arts (EA), and which report quarterly results tomorrow.
Stocks To Watch
Shares of Microchip Technology closed 0.4% higher at 75.46 on the stock market today, but above their 75.00 entry. When it reports fiscal Q4 results after the close Tuesday, analysts expect EPS to jump 51.4% to $1.06, with revenue up 59.4% to $890 million, according to Zacks Research.
Another chip stock, MaxLinear (MXL), edged up 0.15% to 27.84, still in the zone after breaking out in March, falling below the entry last month and then re-entering it. After the close, Wall Street sees Q1 EPS down 34% at 31 cents, with revenue down 14.6% to $88 million.
Video game publisher Electronic Arts ticked 0.1% lower to 95.67 but is near the high end of its buy zone, which maxes out at 96.51. Also after the close, fiscal Q4 EPS is seen surging 50% to 75 cents, as revenue climbs 18.3% to $1.09 billion.
Jazz Pharmaceuticals (JAZZ) slipped 1.5% to 156.72, but is still above its 155.70 entry. Late Tuesday, analysts expect Q1 EPS to rise 4% to $2.35, with revenue gaining 12.5% to $378 million.
The graphics chipmaker reports Q1 results after the close.
Estimates: EPS to increase 43.5% to 66 cents, as revenue grows 46.4% to $1.91 billion, according to Zacks Research.
Stock: Shares ended down 1% at 102.77, dipping below their 50-day average. After hitting a record intraday high of 120.92 in February, Nvidia (NVDA) has consolidated and is in a base with a 121.02 buy point.
Nvidia has been riding high on strong sales of graphics chips for gaming PCs and consoles as well as processors for cloud computing and artificial intelligence platforms, but analysts have warned recently that it’s likely to face difficult year-over-year growth comparisons in the near term.
The travel booking site reports Q1 results after the close.
Estimates: EPS to drop 16.5% to $8.80, while revenue rises 13.3% to $2.15 billion.
Stock: Shares were closed flat at 1903.91 but still near profit-taking sell territory, which starts at 1921.24.
Watch for management to respond to claims from the American Hotel & Lodging Association, which includes Marriott (MAR) and Hyatt (H), that sites like Priceline (PCLN) and Expedia (EXPE) are monopolistic, according to Bloomberg.
The drugmaker reports Q1 results before the market opens.
Estimates: EPS to climb 9.2% to 3.32, while revenue dips 7% to $3.8 billion.
Stock: Shares of Allergan (AGN) fell 1.2% to 241.95 and have moved largely sideways for nearly three months, making their way through a flat base with a 251.04 buy point.[“Source-investors”]